CY 1747
Alternative Names: CY-1747; PB1.3Latest Information Update: 23 Apr 1999
At a glance
- Originator Epimmune
- Developer Epimmune; Sumitomo Pharmaceuticals
- Class Anti-ischaemics; Antithrombotics; Monoclonal antibodies
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cerebrovascular disorders; Ischaemic heart disorders